Yellow fever vaccine-associated adverse events following extensive immunization in Argentina.

Autor: Biscayart C; Programa Nacional de Control de Enfermedades Inmunoprevenibles, Ministerio de Salud de la Nación, Argentina. Electronic address: cristianbiscayart@hotmail.com., Carrega ME; Programa Nacional de Control de Enfermedades Inmunoprevenibles, Ministerio de Salud de la Nación, Argentina., Sagradini S; Programa Nacional de Control de Enfermedades Inmunoprevenibles, Ministerio de Salud de la Nación, Argentina., Gentile A; Sociedad Argentina de Pediatría, Argentina., Stecher D; Sociedad Argentina de Infectología, Argentina., Orduna T; Sociedad Latinoamericana de Medicina del Viajero, Argentina., Bentancourt S; Administración Nacional de Medicamentos, Alimentos y Tecnología Médica, Argentina., Jiménez SG; Pan American Health Organization, Argentina., Flynn LP; Sanatorio Británico, Rosario, Argentina., Arce GP; Sanatorio Rivadavia, San Luis, Argentina., Uboldi MA; Dirección Provincial de Promoción y Prevención de la Salud, Provincia de Santa Fe, Argentina., Bugna L; Dirección Provincial de Promoción y Prevención de la Salud, Provincia de Santa Fe, Argentina., Morales MA; Instituto Nacional de Enfermedades Virales Humanas 'Dr. Julio I. Maiztegui', Pergamino, Argentina., Digilio C; Instituto Nacional de Enfermedades Virales Humanas 'Dr. Julio I. Maiztegui', Pergamino, Argentina., Fabbri C; Instituto Nacional de Enfermedades Virales Humanas 'Dr. Julio I. Maiztegui', Pergamino, Argentina., Enría D; Instituto Nacional de Enfermedades Virales Humanas 'Dr. Julio I. Maiztegui', Pergamino, Argentina., Diosque M; Programa Nacional de Control de Enfermedades Inmunoprevenibles, Ministerio de Salud de la Nación, Argentina., Vizzotti C; Programa Nacional de Control de Enfermedades Inmunoprevenibles, Ministerio de Salud de la Nación, Argentina.
Jazyk: angličtina
Zdroj: Vaccine [Vaccine] 2014 Mar 05; Vol. 32 (11), pp. 1266-72. Date of Electronic Publication: 2014 Jan 21.
DOI: 10.1016/j.vaccine.2014.01.015
Abstrakt: As a consequence of YF outbreaks that hit Brazil, Argentina, and Paraguay in 2008-2009, a significant demand for YF vaccination was subsequently observed in Argentina, a country where the usual vaccine recommendations are restricted to provinces that border Brazil, Paraguay, and Bolivia. The goal of this paper is to describe the adverse events following immunization (AEFI) against YF in Argentina during the outbreak in the northeastern province of Misiones, which occurred from January 2008 to January 2009. During this time, a total of nine cases were reported, almost two million doses of vaccine were administered, and a total of 165 AEFI were reported from different provinces. Case study analyses were performed using two AEFI classifications. Forty-nine events were classified as related to the YF vaccine (24 serious and 1 fatal case), and 12 events were classified as inconclusive. As the use of the YF 17D vaccine can be a challenge to health systems of countries with different endemicity patterns, a careful clinical and epidemiological evaluation should be performed before its prescription to minimize serious adverse events.
(Copyright © 2014 Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: